MEDIFAST DL-,001MEDIFAST DL-,001MEDIFAST DL-,001

MEDIFAST DL-,001

No trades
See on Supercharts
Market capitalization
‪325.48 M‬EUR
‪90.07 M‬EUR
‪971.29 M‬EUR
‪10.60 M‬
Beta (1Y)
0.59

About MEDIFAST DL-,001

CEO
Daniel R. Chard
Headquarters
Baltimore
Employees (FY)
634
Founded
1981
ISIN
US58470H1014
FIGI
BBG000C0BQM1
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MEDIFAST DL-,001 stocks are traded under the ticker MDF.
MEDIFAST DL-,001 is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MEDIFAST DL-,001 has a max estimate of 36.98 EUR and a min estimate of 32.35 EUR.
MDF earnings for the last quarter are 2.01 EUR per share, whereas the estimation was 1.01 EUR resulting in a 99.06% surprise. The estimated earnings for the next quarter are 0.87 EUR per share. See more details about MEDIFAST DL-,001 earnings.
MEDIFAST DL-,001 revenue for the last quarter amounts to ‪223.13 M‬ EUR despite the estimated figure of ‪219.57 M‬ EUR. In the next quarter revenue is expected to reach ‪166.86 M‬ EUR.
Yes, you can track MEDIFAST DL-,001 financials in yearly and quarterly reports right on TradingView.
MDF net income for the last quarter is ‪5.47 M‬ EUR, while the quarter before that showed ‪21.88 M‬ EUR of net income which accounts for −75.01% change. Track more MEDIFAST DL-,001 financial stats to get the full picture.
Yes, MDF dividends are paid quarterly. The last dividend per share was 1.54 EUR. As of today, Dividend Yield (TTM)% is 20.30%. Tracking MEDIFAST DL-,001 dividends might help you take more informed decisions.
Like other stocks, MDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIFAST DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
MDF reached its all-time high on May 25, 2021 with the price of 273.60 EUR, and its all-time low was 1.99 EUR and was reached on Mar 2, 2005.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 634.00 employees. See our rating of the largest employees — is MEDIFAST DL-,001 on this list?
We've gathered analysts' opinions on MEDIFAST DL-,001 future price: according to them, MDF price has a max estimate of 36.98 EUR and a min estimate of 32.35 EUR. Read a more detailed MEDIFAST DL-,001 forecast: see what analysts think of MEDIFAST DL-,001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIFAST DL-,001 EBITDA is ‪130.57 M‬ EUR, and current EBITDA margin is 13.44%. See more stats in MEDIFAST DL-,001 financial statements.